Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Conditions

Accelerated Phase Chronic Myelogenous Leukemia | Acute Myeloid Leukemia/Transient Myeloproliferative Disorder | Acute Undifferentiated Leukemia | Angioimmunoblastic T-cell Lymphoma | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Blastic Phase Chronic Myelogenous Leukemia | Childhood Acute Lymphoblastic Leukemia in Remission | Childhood Acute Myeloid Leukemia in Remission | Childhood Burkitt Lymphoma | Childhood Chronic Myelogenous Leukemia | Childhood Diffuse Large Cell Lymphoma | Childhood Grade III Lymphomatoid Granulomatosis | Childhood Immunoblastic Large Cell Lymphoma | Childhood Myelodysplastic Syndromes | Childhood Nasal Type Extranodal NK/T-cell Lymphoma | Chronic Eosinophilic Leukemia | Chronic Myelomonocytic Leukemia | Chronic Neutrophilic Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Cutaneous B-cell Non-Hodgkin Lymphoma | Essential Thrombocythemia | Extramedullary Plasmacytoma | Intraocular Lymphoma | Isolated Plasmacytoma of Bone | Juvenile Myelomonocytic Leukemia | Long-term Effects Secondary to Cancer Therapy in Children | Mast Cell Leukemia | Meningeal Chronic Myelogenous Leukemia | Monoclonal Gammopathy of Undetermined Significance | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable | Polycythemia Vera | Post-transplant Lymphoproliferative Disorder | Primary Central Nervous System Hodgkin Lymphoma | Primary Central Nervous System Non-Hodgkin Lymphoma | Primary Myelofibrosis | Primary Systemic Amyloidosis | Progressive Hairy Cell Leukemia, Initial Treatment | Prolymphocytic Leukemia | Secondary Acute Myeloid Leukemia | Secondary Myelodysplastic Syndromes | Stage 0 Chronic Lymphocytic Leukemia | Stage I Childhood Anaplastic Large Cell Lymphoma | Stage I Childhood Hodgkin Lymphoma | Stage I Childhood Large Cell Lymphoma | Stage I Childhood Lymphoblastic Lymphoma | Stage I Childhood Small Noncleaved Cell Lymphoma | Stage I Chronic Lymphocytic Leukemia | Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Multiple Myeloma | Stage I Mycosis Fungoides/Sezary Syndrome | Stage II Childhood Anaplastic Large Cell Lymphoma | Stage II Childhood Hodgkin Lymphoma | Stage II Childhood Large Cell Lymphoma | Stage II Childhood Lymphoblastic Lymphoma | Stage II Childhood Small Noncleaved Cell Lymphoma | Stage II Chronic Lymphocytic Leukemia | Stage II Cutaneous T-cell Non-Hodgkin Lymphoma | Stage II Multiple Myeloma | Stage II Mycosis Fungoides/Sezary Syndrome | Stage III Childhood Anaplastic Large Cell Lymphoma | Stage III Childhood Hodgkin Lymphoma | Stage III Childhood Large Cell Lymphoma | Stage III Childhood Lymphoblastic Lymphoma | Stage III Childhood Small Noncleaved Cell Lymphoma | Stage III Chronic Lymphocytic Leukemia | Stage III Cutaneous T-cell Non-Hodgkin Lymphoma | Stage III Multiple Myeloma | Stage III Mycosis Fungoides/Sezary Syndrome | Stage IV Childhood Anaplastic Large Cell Lymphoma | Stage IV Childhood Hodgkin Lymphoma | Stage IV Childhood Large Cell Lymphoma | Stage IV Childhood Lymphoblastic Lymphoma | Stage IV Childhood Small Noncleaved Cell Lymphoma | Stage IV Chronic Lymphocytic Leukemia | Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IV Mycosis Fungoides/Sezary Syndrome | T-cell Large Granular Lymphocyte Leukemia | Unspecified Childhood Solid Tumor, Protocol Specific | Untreated Childhood Acute Lymphoblastic Leukemia | Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies | Untreated Hairy Cell Leukemia | Waldenström Macroglobulinemia

What is the purpose of this trial?


Participation Guidelines

Age:
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Children's Oncology Group
National Cancer Institute (NCI)
Dates:
May 2008
Last Updated:
February 5, 2014
Study HIC#:
0909005705

Clinicaltrials.gov ID: NCT00736749